Haemophilus influenzae and pneumococci: Co-colonization, interactions, cooperation and competition.

biofilms chronic suppurative lung disorders otitis media pneumonia vaccines

Journal

Pediatric pulmonology
ISSN: 1099-0496
Titre abrégé: Pediatr Pulmonol
Pays: United States
ID NLM: 8510590

Informations de publication

Date de publication:
11 Oct 2024
Historique:
received: 25 08 2024
accepted: 26 09 2024
medline: 11 10 2024
pubmed: 11 10 2024
entrez: 11 10 2024
Statut: aheadofprint

Résumé

Nontypeable Haemophilus influenzae (NTHi) and Streptococcus pneumoniae (pneumococcus) are pathobionts that share common environmental niches within the upper respiratory tract. They can form part of the resident upper airway microbiota, but under certain environmental circumstances become pathogenic and induce disease. In children, both organisms have a considerable impact on the healthcare system, commonly causing acute otitis media and pneumonia. They are also associated with chronic biofilm-mediated respiratory infections, such as persistent middle ear effusions and chronic suppurative otitis media, and in the lower airways with protracted bacterial bronchitis and bronchiectasis. Consequently, both organisms are responsible for large numbers of antibiotic prescriptions and substantial healthcare costs. The complex relationship between NTHi and pneumococcal co-interaction during colonization, infection and biofilm formation is poorly understood and a greater understanding is needed to facilitate development of future therapies, and novel interventions and prevention strategies. Co-infections with both bacteria can result in more severe disease, with disease severity likely mediated by their ability to cooperate in some in vivo niches. However, this relationship is not always straightforward, as under certain conditions, these two bacteria compete rather than cooperate. Current opinion supports developing a vaccine targeting NTHi strains, as well as a combined vaccine targeting both NTHi and pneumococci to decrease the respiratory disease burden in young children. This review summarizes our current knowledge of the interactions between NTHi and pneumococci and speculates on the future directions of research to understand how these bacteria co-exist and how to better prevent and treat NTHi and pneumococcal infection.

Identifiants

pubmed: 39392258
doi: 10.1002/ppul.27318
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Health and Medical Research Council
ID : GNT1170958

Informations de copyright

© 2024 Wiley Periodicals LLC.

Références

Ikuta KS, Swetschinski LR, Robles Aguilar G, et al. GBD 2019 Antimicrobial Resistance Collaborators Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022;400(10369):2221‐2248. doi:10.1016/s0140-6736(22)02185-7
Schilder AGM, Chonmaitree T, Cripps AW, et al. Otitis media. Nat Rev Dis Primers. 2016;2(1):16063. doi:10.1038/nrdp.2016.63
Jain S, Williams DJ, Arnold SR, et al. Community‐acquired pneumonia requiring hospitalization among US children. N Engl J Med. 2015;372(9):835‐845. doi:10.1056/NEJMoa1405870
O'Brien KL, Baggett HC, Brooks WA, et al. The Pneumonia Etiology Research for Child Health (PERCH) Study Group Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi‐country case‐control study. The Lancet. 2019;394(10200):757‐779. doi:10.1016/s0140-6736(19)30721-4
Slack MPE. The evidence for non‐typeable Haemophilus influenzae as a causative agent of childhood pneumonia. Pneumonia. 2017;9:9. doi:10.1186/s41479-017-0033-2
Yildirim I, Lapidot R, Shaik‐Dasthagirisaheb YB, et al. Invasive pneumococcal disease after 2 decades of pneumococcal conjugate vaccine use. Pediatrics. 2024;153(1). doi:10.1542/peds.2023-063039
Oliver SE, Rubis AB, Soeters HM, et al. Epidemiology of invasive nontypeable Haemophilus influenzae disease‐United States, 2008‐2019. Clin Infect Dis. 2023;76(11):1889‐1895. doi:10.1093/cid/ciad054
Mills N, Best EJ, Murdoch D, et al. What is behind the ear drum? The microbiology of otitis media and the nasopharyngeal flora in children in the era of pneumococcal vaccination. J Paediatr Child Health. 2015;51(3):300‐306. doi:10.1111/jpc.12710
Bhutta MF, Leach AJ, Brennan‐Jones CG. Chronic suppurative otitis media. The Lancet. 2024;403(10441):2339‐2348. doi:10.1016/s0140-6736(24)00259-9
de Vries JJV, Chang AB, Marchant JM. Comparison of bronchoscopy and bronchoalveolar lavage findings in three types of suppurative lung disease. Pediatr Pulmonol. 2018;53(4):467‐474. doi:10.1002/ppul.23952
Marsh RL, Binks MJ, Smith‐Vaughan HC, et al. Prevalence and subtyping of biofilms present in bronchoalveolar lavage from children with protracted bacterial bronchitis or non‐cystic fibrosis bronchiectasis: a cross‐sectional study. The Lancet Microbe. 2022;3(3):e215‐e223. doi:10.1016/s2666-5247(21)00300-1
Monasta L, Ronfani L, Marchetti F, et al. Burden of disease caused by otitis media: systematic review and global estimates. PLoS One. 2012;7(4):e36226. doi:10.1371/journal.pone.0036226
Ahmed S, Shapiro NL, Bhattacharyya N. Incremental health care utilization and costs for acute otitis media in children. Laryngoscope. 2014;124(1):301‐305. doi:10.1002/lary.24190
Suaya JA, Gessner BD, Fung S, et al. Acute otitis media, antimicrobial prescriptions, and medical expenses among children in the United States during 2011‐2016. Vaccine. 2018;36(49):7479‐7486. doi:10.1016/j.vaccine.2018.10.060
GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators. Global, regional, and national incidence and mortality burden of non‐COVID‐19 lower respiratory infections and aetiologies, 1990‐2021: a systematic analysis from the Global Burden of Disease Study 2021. Lancet Infect Dis. 2024;24(9):974‐1002. doi:10.1016/s1473-3099(24)00176-2
Chang AB, Robertson CF, Van Asperen PP, et al. A multicenter study on chronic cough in children. Chest. 2012;142(4):943‐950. doi:10.1378/chest.11-2725
Ruffles TJC, Marchant JM, Masters IB, et al. Outcomes of protracted bacterial bronchitis in children: a 5‐year prospective cohort study. Respirology. 2021;26(3):241‐248. doi:10.1111/resp.13950
Roberts JM, Goyal V, Kularatna S, et al. The economic burden of bronchiectasis. Chest. 2023;164(6):1396‐1421. doi:10.1016/j.chest.2023.06.040
Walter EB, Smith MJ. Prevention of pneumococcal infections in childhood: two decades of progress. Curr Opin Pediatr. 2022;34(2):140‐146. doi:10.1097/mop.0000000000001112
Murray C, Ikuta KS, Sharara F, et al. Antimicrobial Resistance Collaborators Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet. 2022;399(10325):629‐655. doi:10.1016/s0140-6736(21)02724-0
Heinz E. The return of Pfeiffer's bacillus: rising incidence of ampicillin resistance in Haemophilus influenzae. Microb Genom. 2018;4(9):e000214. doi:10.1099/mgen.0.000214
Centers for Disease Control and Prevention. CDC's 2019 Antibiotic Resistance Threats Report. Accessed July 23, 2024. www.CDC.gov/DrugResistance/Biggest-Threats.html
WHO Bacterial Pathogen Priority List, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. World Health Organization; 2024.
Anju VT, Busi S, Imchen M, et al. Polymicrobial infections and biofilms: clinical significance and eradication strategies. Antibiotics. 2022;11(12):1731. doi:10.3390/antibiotics11121731
Xu Q, Wischmeyer J, Gonzalez E, Pichichero ME. Nasopharyngeal polymicrobial colonization during health, viral upper respiratory infection and upper respiratory bacterial infection. J Infect. 2017;75(1):26‐34. doi:10.1016/j.jinf.2017.04.003
Bair KL, Campagnari AA. Moraxella catarrhalis promotes stable polymicrobial biofilms with the major otopathogens. Front Microbiol. 2020;10:3006. doi:10.3389/fmicb.2019.03006
Liu YN, Zhang YF, Xu Q, et al. Infection and co‐infection patterns of community‐acquired pneumonia in patients of different ages in China from 2009 to 2020: a national surveillance study. Lancet Microbe. 2023;4(5):e330‐e339. doi:10.1016/s2666-5247(23)00031-9
Papadopoulos NG, Apostolidou E, Miligkos M, Xepapadaki P. Bacteria and viruses and their role in the preschool wheeze to asthma transition. Pediatr Allergy Immunol. 2024;35(3):e14098. doi:10.1111/pai.14098
Sohail I, Ghosh S, Mukundan S, Zelewski S, Khan MN. Role of inflammatory risk factors in the pathogenesis of Streptococcus pneumoniae. Front Immunol. 2018;9:2275. doi:10.3389/fimmu.2018.02275
Ackland J, Watson A, Wilkinson TMA, Staples KJ. Interrupting the conversation: implications for crosstalk between viral and bacterial infections in the asthmatic airway. Front Allergy. 2021;2:738987. doi:10.3389/falgy.2021.738987
Teo SM, Mok D, Pham K, et al. The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development. Cell Host Microbe. 2015;17(5):704‐715. doi:10.1016/j.chom.2015.03.008
Teo SM, Tang HHF, Mok D, et al. Airway microbiota dynamics uncover a critical window for interplay of pathogenic bacteria and allergy in childhood respiratory disease. Cell Host Microbe. 2018;24(3):341‐352.e5. doi:10.1016/j.chom.2018.08.005
Dunne EM, Murad C, Sudigdoadi S, et al. Carriage of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in Indonesian children: a cross‐sectional study. PLoS One. 2018;13(4):e0195098. doi:10.1371/journal.pone.0195098
Giucă MC, Cîlcic C, Mihăescu G, Gavrilă A, Dinescu M, Gătej RI. Streptococcus pneumoniae and Haemophilus influenzae nasopharyngeal molecular detection in children with acute respiratory tract infection in SANADOR Hospital, Romania. J Med Microbiol. 2019;68(10):1466‐1470. doi:10.1099/jmm.0.001038
Kovács E, Sahin‐Tóth J, Tóthpál A, van der Linden M, Tirczka T, Dobay O. Co‐carriage of Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis among three different age categories of children in Hungary. PLoS One. 2020;15(2):e0229021. doi:10.1371/journal.pone.0229021
Dagan R, Leibovitz E, Greenberg D, Bakaletz L, Givon‐Lavi N. Mixed pneumococcal‐nontypeable Haemophilus influenzae otitis media is a distinct clinical entity with unique epidemiologic characteristics and pneumococcal serotype distribution. J Infect Dis. 2013;208(7):1152‐1160. doi:10.1093/infdis/jit289
Tikhomirova A, Kidd SP. Haemophilus influenzae and Streptococcus pneumoniae: living together in a biofilm. Pathog Dis. 2013;69(2):114‐126. doi:10.1111/2049-632x.12073
Tikhomirova A, Trappetti C, Paton JC, Kidd SP. The outcome of H. influenzae and S. pneumoniae inter‐species interactions depends on pH, nutrient availability and growth phase. IJMM. 2015;305(8):881‐892. doi:10.1016/j.ijmm.2015.09.003
Tikhomirova A, Trappetti C, Standish AJ, et al. Specific growth conditions induce a Streptococcus pneumoniae non‐mucoidal, small colony variant and determine the outcome of its co‐culture with Haemophilus influenzae. Pathog Dis. 2018;76(7):fty074. doi:10.1093/femspd/fty074
Osgood R, Salamone F, Diaz A, Casey JR, Bajorski P, Pichichero ME. Effect of pH and oxygen on biofilm formation in acute otitis media associated NTHi clinical isolates. Laryngoscope. 2015;125(9):2204‐2208. doi:10.1002/lary.25102
Hong W, Khampang P, Erbe C, Kumar S, Taylor SR, Kerschner JE. Nontypeable Haemophilus influenzae inhibits autolysis and fratricide of Streptococcus pneumoniae in vitro. Microb Infect. 2014;16(3):203‐213. doi:10.1016/j.micinf.2013.11.006
Gonzalez K, Faustoferri RC, Quivey Jr. RG. Role of DNA base excision repair in the mutability and virulence of Streptococcus mutans. Mol Microbiol. 2012;85(2):361‐377. doi:10.1111/j.1365-2958.2012.08116.x
Tikhomirova A, Zilm PS, Trappetti C, Paton JC, Kidd SP. The central role of arginine in Haemophilus influenzae survival in a polymicrobial environment with Streptococcus pneumoniae and Moraxella catarrhalis. PLoS One. 2022;17(7):e0271912. doi:10.1371/journal.pone.0271912
Bowler P, Murphy C, Wolcott R. Biofilm exacerbates antibiotic resistance: is this a current oversight in antimicrobial stewardship? Antimicrob Resist Infect Control. 2020;9(1):162. doi:10.1186/s13756-020-00830-6
Jennelle MK, Ajay K, Stephen K. Interactions and mechanisms of respiratory tract biofilms involving Streptococcus pneumoniae and nontypeable Haemophilus influenzae. In: Dharumadurai D, Nooruddin T, eds, Microbial Biofilms. IntechOpen; 2016:299‐328.
Mirghani R, Saba T, Khaliq H, et al. Biofilms: formation, drug resistance and alternatives to conventional approaches. AIMS Microbiology. 2022;8(3):239‐277. doi:10.3934/microbiol.2022019
Krishnamurthy A, Kyd J. The roles of epithelial cell contact, respiratory bacterial interactions and phosphorylcholine in promoting biofilm formation by Streptococcus pneumoniae and nontypeable Haemophilus influenzae. Microb Infect. 2014;16(8):640‐647. doi:10.1016/j.micinf.2014.06.008
Weimer KED, Juneau RA, Murrah KA, et al. Divergent mechanisms for passive pneumococcal resistance to β‐lactam antibiotics in the presence of Haemophilus influenzae. J Infect Dis. 2011;203(4):549‐555. doi:10.1093/infdis/jiq087
Su P‐Y, Cheng W‐H, Ho C‐H. Molecular characterization of multidrug‐resistant non‐typeable Haemophilus influenzae with high‐level resistance to cefuroxime, levofloxacin, and trimethoprim‐sulfamethoxazole. BMC Microbiol. 2023;23(1):178. doi:10.1186/s12866-023-02926-6
Cope EK, Goldstein‐Daruech N, Kofonow JM, et al. Regulation of virulence gene expression resulting from Streptococcus pneumoniae and nontypeable Haemophilus influenzae interactions in chronic disease. PLoS One. 2011;6(12):e28523. doi:10.1371/journal.pone.0028523
Lim J, Ha U, Sakai A, et al. Streptococcus pneumoniae synergizes with nontypeable Haemophilus influenzae to induce inflammation via upregulating TLR2. BMC Immunol. 2008;9:40. doi:10.1186/1471-2172-9-40
Lewnard JA, Huppert A, Givon‐Lavi N, et al. Density, serotype diversity, and fitness of Streptococcus pneumoniae in upper respiratory tract cocolonization with nontypeable Haemophilus influenzae. J Infect Dis. 2016;214(9):1411‐1420. doi:10.1093/infdis/jiw381
Palmu AA, Ware RS, Lambert SB, et al. Nasal swab bacteriology by PCR during the first 24‐months of life: a prospective birth cohort study. Pediatr Pulmonol. 2019;54(3):289‐296. doi:10.1002/ppul.24231
Besteman SB, Bogaert D, Bont L, et al. Interactions between respiratory syncytial virus and Streptococcus pneumoniae in the pathogenesis of childhood respiratory infections: a systematic review. Lancet Respir Med. Published online, July 8, 2024. Priprint. doi:10.1016/s2213-2600(24)00148-6
Madhi SA, Klugman KP, The Vaccine Trialist Group. A role for Streptococcus pneumoniae in virus‐associated pneumonia. Nature Med. 2004;10(8):811‐813. doi:10.1038/nm1077
Olwagen CP, Downs SL, Izu A, et al. Bacterial nasopharyngeal colonisation in children in South Africa before and during the COVID‐19 pandemic: an observational study. Lancet Microbe. 2024;5(1):e34‐e42. doi:10.1016/s2666-5247(23)00260-4
Avadhanula V, Wang Y, Portner A, Adderson E. Nontypeable Haemophilus influenzae and Streptococcus pneumoniae bind respiratory syncytial virus glycoprotein. J Med Microbiol. 2007;56(Pt 9):1133‐1137. doi:10.1099/jmm.0.47086-0
Lalbiaktluangi C, Yadav MK, Singh PK, et al. A cooperativity between virus and bacteria during respiratory infections. Front Microbiol. 2023;14:1279159. doi:10.3389/fmicb.2023.1279159
Diaz‐Diaz A, Bunsow E, Garcia‐Maurino C, et al. Nasopharyngeal codetection of Haemophilus influenzae and Streptococcus pneumoniae shapes respiratory syncytial virus disease outcomes in children. J Infect Dis. 2022;225(5):912‐923. doi:10.1093/infdis/jiab481
Lewnard JA, Givon‐Lavi N, Tähtinen PA, Dagan R. Pneumococcal phenotype and interaction with nontypeable Haemophilus influenzae as determinants of otitis media progression. Infect Immun. 2018;86(6):e00727‐17. doi:10.1128/iai.00727-17
Murphy TF, Bakaletz LO, Smeesters PR. Microbial interactions in the respiratory tract. Pediatr Infect Dis J. 2009;28(10 suppl):S121‐S126. doi:10.1097/INF.0b013e3181b6d7ec
Vermee Q, Cohen R, Hays C, et al. Biofilm production by Haemophilus influenzae and Streptococcus pneumoniae isolated from the nasopharynx of children with acute otitis media. BMC Infect Dis. 2019;19(1):44. doi:10.1186/s12879-018-3657-9
Perdrizet J, Horn EK, Hayford K, et al. Historical population‐level impact of infant 13‐valent pneumococcal conjugate vaccine (PCV13) national immunization programs on invasive pneumococcal disease in Australia, Canada, England and Wales, Israel, and the United States. Infect Dis Ther. 2023;12(5):1351‐1364. doi:10.1007/s40121-023-00798-x
Wasserman M, Chapman R, Lapidot R, et al. Twenty‐year public health impact of 7‐ and 13‐valent pneumococcal conjugate vaccines in US children. Emerging Infect Dis. 2021;27(6):1627‐1636. doi:10.3201/eid2706.204238
Andrejko K, Ratnasiri B, Hausdorff WP, Laxminarayan R, Lewnard JA. Antimicrobial resistance in paediatric Streptococcus pneumoniae isolates amid global implementation of pneumococcal conjugate vaccines: a systematic review and meta‐regression analysis. Lancet Microbe. 2021;2(9):e450‐e460. doi:10.1016/s2666-5247(21)00064-1
Andrejko KL, Gierke R, Rowlands JV, et al. Effectiveness of 13‐valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease among children in the United States between 2010 and 2019: an indirect cohort study. Vaccine. 2024;42(16):3555‐3563. doi:10.1016/j.vaccine.2024.04.061
Grant LR, Apodaca K, Deshpande L, et al. Characterization of Streptococcus pneumoniae isolates obtained from the middle ear fluid of US children, 2011‐2021. Front Pediatr. 2024;12:1383748. doi:10.3389/fped.2024.1383748
Méroc E, Fletcher MA, Hanquet G, et al. Systematic literature review of the epidemiological characteristics of pneumococcal disease caused by the additional serotypes covered by the 20‐valent pneumococcal conjugate vaccine. Microorganisms. 2023;11(7):1816. doi:10.3390/microorganisms11071816
Senders S, Klein NP, Tamimi N, et al. A phase three study of the safety and immunogenicity of a four‐dose series of 20‐valent pneumococcal conjugate vaccine in healthy infants. Pediatr Infect Dis J. 2024;43(6):596‐603. doi:10.1097/inf.0000000000004334
Li S, Liang H, Zhao SH, Yang XY, Guo Z. Recent progress in pneumococcal protein vaccines. Front Immunol. 2023;14:1278346. doi:10.3389/fimmu.2023.1278346
Slack MPE, Cripps AW, Grimwood K, Mackenzie GA, Ulanova M. Invasive Haemophilus influenzae infections after 3 decades of Hib protein conjugate vaccine use. Clin Microbiol Rev. 2021;34(3):e0002821. doi:10.1128/cmr.00028-21
Phillips ZN, Jennison AV, Whitby PW, Stull TL, Staples M, Atack JM. Examination of phase‐variable haemoglobin‐haptoglobin binding proteins in non‐typeable Haemophilus influenzae reveals a diverse distribution of multiple variants. FEMS Microbiol Lett. 2022;369(1):fnac064. doi:10.1093/femsle/fnac064
Chatziparasidis G, Kantar A, Grimwood K. Pathogenesis of nontypeable Haemophilus influenzae infections in chronic suppurative lung disease. Pediatr Pulmonol. 2023;58(7):1849‐1860. doi:10.1002/ppul.26446
Jalalvand F, Riesbeck K. Update on non‐typeable Haemophilus influenzae‐mediated disease and vaccine development. Expert Rev Vaccines. 2018;17(6):503‐512. doi:10.1080/14760584.2018.1484286
Zahid A, Wilson JC, Grice ID, Peak IR. Otitis media: recent advances in otitis media vaccine development and model systems. Front Microbiol. 2024;15:1345027. doi:10.3389/fmicb.2024.1345027
Clarke C, Bakaletz LO, Ruiz‐Guiñazú J, Borys D, Mrkvan T. Impact of protein D‐containing pneumococcal conjugate vaccines on non‐typeable Haemophilus influenzae acute otitis media and carriage. Expert Rev Vaccines. 2017;16(7):751‐764. doi:10.1080/14760584.2017.1333905
Martinovich KM, Rahman T, de Gier C, et al. Differences in pneumococcal and Haemophilus influenzae natural antibody development in Papua New Guinean children in the first year of life. Front Immunol. 2021;12:725244. doi:10.3389/fimmu.2021.725244
Andrade DC, Borges IC, Bouzas ML, et al. Antibody responses against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in children with acute respiratory infection with or without nasopharyngeal bacterial carriage. Infect Dis. 2018;50(9):705‐713. doi:10.1080/23744235.2018.1463451
Plosker GL. 10‐Valent pneumococcal non‐typeable haemophilus influenzae protein D‐conjugate vaccine: a review in infants and children. Pediatric Drugs. 2014;16(5):425‐444. doi:10.1007/s40272-014-0089-x
van den Bergh MR, Spijkerman J, Swinnen KM, et al. Effects of the 10‐valent pneumococcal nontypeable Haemophilus influenzae protein D‐conjugate vaccine on nasopharyngeal bacterial colonization in young children: a randomized controlled trial. Clin Infect Dis. 2013;56(3):e30‐e39. doi:10.1093/cid/cis922
Sveinsdóttir H, Björnsdóttir JB, Erlendsdóttir H, et al. The effect of the 10‐valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine on H. influenzae in healthy carriers and middle ear infections in Iceland. J Clin Microbiol. 2019;57(7):e00116‐19. doi:10.1128/jcm.00116-19
Leach AJ, Wilson N, Arrowsmith B, et al. Otitis media at 6‐monthly assessments of Australian first nations children between ages 12‐36 months: findings from two randomised controlled trials of combined pneumococcal conjugate vaccines. Int J Pediatr Otorhinolaryngol. 2023;175:111776. doi:10.1016/j.ijporl.2023.111776
Leach AJ, Wilson N, Arrowsmith B, et al. Hearing loss in Australian first nations children at 6‐monthly assessments from age 12 to 36 months: secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedules. PLoS Med. 2024;21(6):e1004375. doi:10.1371/journal.pmed.1004375
Binks MJ, Beissbarth J, Oguoma VM, et al. Acute lower respiratory infections in indigenous infants in Australia's Northern Territory across three eras of pneumococcal conjugate vaccine use (2006‐15): a population‐based cohort study. Lancet Child Adolesc Health. 2020;4(6):425‐434. doi:10.1016/s2352-4642(20)30090-0
O'grady KF, Chang AB, Cripps A, et al. The clinical, immunological and microbiological impact of the 10‐valent pneumococcal‐protein D conjugate vaccine in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: a multi‐centre, double‐blind, randomised controlled trial. Hum Vaccines Immunother. 2018;14(11):2768‐2779. doi:10.1080/21645515.2018.1488562
Smith‐Vaughan HC, Chang AB, Sarovich DS, et al. Absence of an important vaccine and diagnostic target in carriage‐ and disease‐related nontypeable Haemophilus influenzae. Clin Vaccine Immunol. 2014;21(2):250‐252. doi:10.1128/cvi.00632-13
Iuchi H, Ohori J, Kyutoku T, Ito K, Kurono Y. Role of phosphorylcholine in Streptococcus pneumoniae and nontypeable Haemophilus influenzae adherence to epithelial cells. Auris Nasus Larynx. 2019;46(4):513‐519. doi:10.1016/j.anl.2018.11.003
Domenech M, García E. N‐acetyl‐l‐cysteine and cysteamine as new strategies against mixed biofilms of nonencapsulated Streptococcus pneumoniae and nontypeable Haemophilus influenzae. Antimicrob Agents Chemother. 2017;61(2):e01992‐16. doi:10.1128/aac.01992-16

Auteurs

Finn McMahon (F)

Institute for Biomedicine and Glycomics, Griffith University, Gold Coast, Queensland, Australia.

Robert S Ware (RS)

Health Group, Griffith University, Gold Coast, Queensland, Australia.

Keith Grimwood (K)

School of Medicine and Dentistry, Griffith University, Gold Coast, Queensland, Australia.
NHMRC Centre for Research Excellence in Paediatric Bronchiectasis (AusBREATHE), Child Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.

John M Atack (JM)

Institute for Biomedicine and Glycomics, Griffith University, Gold Coast, Queensland, Australia.
School of Environment and Science, Griffith University, Gold Coast, Queensland, Australia.

Classifications MeSH